CAR T-Cell Therapy Follow-Up Monitoring | What Patients Can Expect
CAR T-Cell Therapy Follow-Up Monitoring | What Patients Can Expect from Patient Empowerment Network on Vimeo. What can CAR T-cell therapy patients expect for follow-up monitoring? Expert Dr. Krina Patel…
What Are CAR T-Cell Therapy Requirements for Care Partners?
https://vimeo.com/944188734 What requirements do CAR T-cell therapy care partners need to meet? Expert Dr. Krina Patel from The University of Texas MD Anderson Cancer Center discusses CAR T-cell therapy care partner requirements,…
What Is the Impact of CAR T-Cell Therapy Access Barriers on Patients?
https://vimeo.com/944188840 How do CAR T-cell therapy access barriers impact patients? Expert Dr. Krina Patel from The University of Texas MD Anderson Cancer Center discusses factors that create CAR T-cell therapy access barriers…
A Look at Promising Strategies to Improve CAR T-Cell Therapy Access
A Look at Promising Strategies to Improve CAR T-Cell Therapy Access from Patient Empowerment Network on Vimeo. How can CAR T-cell therapy access be improved? Expert Dr. Krina Patel from…
Are There Myeloma Trials Investigating CAR T for Frontline Therapy?
Are There Myeloma Trials Investigating CAR T for Frontline Therapy? from Patient Empowerment Network on Vimeo. Is it possible for CAR T-cell therapy to be used as a frontline therapy?…
How Can Variable Patient Groups Be Addressed in CAR T?
https://vimeo.com/944065239 Can CAR T-cell therapy address variable patient groups? Expert Dr. Krina Patel from The University of Texas MD Anderson Cancer Center discusses variances in different myeloma patient groups, the KarMMa-3 study,…
What Patient Types Are Good Candidates for CAR T-Cell Therapy?
What Patient Types Are Good Candidates for CAR T-Cell Therapy? from Patient Empowerment Network on Vimeo. For CAR T-cell therapy, what patient types are good candidates? Expert Dr. Krina Patel…
Understanding Myeloma | How You Can Collaborate in Your Care
https://vimeo.com/942111089 This animated video reviews the types of myeloma, essential testing following a myeloma diagnosis, and advice for working with your healthcare team for the best overall care. See More…
How Can Bispecific Antibody Therapy Care Partners Be Proactive?
https://vimeo.com/940909348 What are some ways for myeloma bispecific antibody therapy care partners to be proactive? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute shares lifestyle modifications, reasons to speak up…
Bispecific Antibody Therapy Support | Care Team Members and Resources
https://vimeo.com/940909300 What should myeloma patients know about bispecific antibody therapy support? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute discusses care team members and support resources for bispecific antibody therapy…
What Is the Role of a Care Partner in Bispecific Antibody Therapy?
https://vimeo.com/940909265 How can a myeloma care partner support a bispecific antibody therapy patient? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute explains ways that care partners can offer logistical and…
Bispecific Antibody Therapy | What Is the Treatment Duration and Response?
https://vimeo.com/940909235 What can myeloma bispecific antibody therapy patients expect for treatment duration and response? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute discusses treatment factors that may impact response, common…